CRYSTALLINE FORMS OF (R)-1-{2-[4`- (3-METHOXY-PROPANE-1- SULFONYL)-BIPHENYL-4-YL]-ETHYL}-2-METHYL-PYRROLIDINE, AND COMPOSITIONS, AND METHODS RELATED THERETO
申请人:Blackburn Anthony C.
公开号:US20100292288A1
公开(公告)日:2010-11-18
The present invention is directed to novel salts of (R)-1-2-[4′-(3-methoxy-propane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and crystalline forms, and compositions thereof that modulate the activity of the histamine H3-receptor and are useful in the treatment of histamine H3-receptor associated disorders, such as, cognitive disorders, epilepsy, brain trauma, depression, obesity, disorders of sleep and wakefulness such as narcolepsy, shift-work syndrome, drowsiness as a side effect from a medication, maintenance of vigilance to aid in completion of tasks and the like, cataplexy, hypersomnia, somnolence syndrome, jet lag, sleep apnea and the like, attention deficit hyperactivity disorder (ADHD), schizophrenia, allergies, allergic responses in the upper airway, allergic rhinitis, nasal congestion, pain, dementia, Alzheimer's disease and the like.
本发明涉及(R)-1-2-[4′-(3-甲氧基丙烷-1-磺酰基)-联苯-4-基]-乙基}-2-甲基-吡咯烷的新型盐、晶体形式和组合物,该组合物调节组胺H3受体的活性,并用于治疗与组胺H3受体相关的疾病,例如认知障碍、癫痫、脑外伤、抑郁症、肥胖症、睡眠和觉醒障碍,如嗜睡症、倒班综合征、药物副作用引起的嗜睡、保持警觉以帮助完成任务等,病理性睡眠病、过度睡眠综合征、嗜睡综合征、时差反应、睡眠呼吸暂停等、注意力缺陷多动障碍(ADHD)、精神分裂症、过敏、上呼吸道过敏反应、过敏性鼻炎、鼻塞、疼痛、痴呆、阿尔茨海默病等。